SUSAN VINCENT: Open Payments
NPI 1356113427 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 76 payments from 13 companies in 2025. Trend: 2023 $49 · 2024 $1,922 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 13 | $313 |
| Supernus Pharmaceuticals, Inc. | 24 | $207 |
| Janssen Pharmaceuticals, Inc | 6 | $205 |
| ABBVIE INC. | 9 | $170 |
| Alkermes, Inc. | 6 | $117 |
| Lundbeck LLC | 5 | $112 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $48 |
| Indivior Inc. | 1 | $30 |
Products named: Azstarys, Qelbree, SPRAVATO, REXULTI, VRAYLAR, LYBALVI, Auvelity, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
